Skip to main content
UploadLanguage (EN)Support
BusinessMobileSocial MediaMarketingTechnologyArt & PhotosCareerDesignEducationPresentations & Public SpeakingGovernment & NonprofitHealthcareInternetLawLeadership & ManagementAutomotiveEngineeringSoftwareRecruiting & HRRetailSalesServicesScienceSmall Business & EntrepreneurshipFoodEnvironmentEconomy & FinanceData & AnalyticsInvestor RelationsSportsSpiritualNews & PoliticsTravelSelf ImprovementReal EstateEntertainment & HumorHealth & MedicineDevices & HardwareLifestyle
Parul University, Vadodara, Gujarat, profile picture
Uploaded byParul University, Vadodara, Gujarat
PPTX, PDF78 views

Comprehensive Overview of Non-Clinical Studies in Drug Development

Explore the role of non-clinical studies in drug efficacy, safety, pharmacokinetics, toxicology, GLP, and regulatory requirements before IND submission.

Health & Medicineâ—¦
Related topics:
Preclinical Studies•
Download to read offline
Learning Objectives After this lecture students should be able to âś“ Explain the importance of non-clinical studies âś“ Describe different pharmacology studies âś“ Understand ADME evaluation âś“ Explain major toxicology studies âś“ Understand Good Laboratory Practice (GLP) âś“ Explain regulatory expectations before IND submission
Objectives of Non-Clinical Studies The major objectives are Demonstrate efficacy Does the drug produce the desired biological effect? Evaluate safety Identify possible adverse effects. Determine dose Estimate safe starting dose for first-in-human studies. Understand pharmacokinetics How the drug behaves inside the body. Support IND application Provide evidence that human exposure is reasonably safe.
Why Are Non-Clinical Studies Important? They help answer âś” Does the drug work? âś” Is it safe? âś” Which organs are affected? âś” What dose should be tested? âś” Can the study proceed to humans? Without adequate non-clinical evidence, regulatory agencies will not permit clinical trials.
Summary âś“ Non-clinical studies bridge drug discovery and human clinical trials. âś“ They establish proof of concept, characterize pharmacology, and identify potential safety risks. âś“ ADME studies define how the drug is absorbed, distributed, metabolized, and eliminated. âś“ Toxicology studies determine target-organ toxicity and support safe dose selection. âś“ GLP ensures the quality, integrity, and reliability of non-clinical data. âś“ A comprehensive non-clinical package is essential for regulatory review and successful IND submission.
Comprehensive Overview of Non-Clinical Studies in Drug Development